panipenem-betamipron has been researched along with ljc 10627 in 3 studies
| Studies (panipenem-betamipron) | Trials (panipenem-betamipron) | Recent Studies (post-2010) (panipenem-betamipron) | Studies (ljc 10627) | Trials (ljc 10627) | Recent Studies (post-2010) (ljc 10627) |
|---|---|---|---|---|---|
| 68 | 17 | 7 | 176 | 31 | 52 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araake, M; Hara, T; Watabe, H | 1 |
| Inoue, M; Kaku, M; Nasu, M; Sagawa, K; Yokoyama, T | 1 |
| Bonomo, RA; Endimiani, A; Papp-Wallace, KM; Taracila, MA | 1 |
1 review(s) available for panipenem-betamipron and ljc 10627
| Article | Year |
|---|---|
Carbapenems: past, present, and future.
Topics: Anti-Bacterial Agents; beta-Alanine; beta-Lactams; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Doripenem; Drug Combinations; Ertapenem; Humans; Imipenem; Thienamycins | 2011 |
2 other study(ies) available for panipenem-betamipron and ljc 10627
| Article | Year |
|---|---|
[Antibacterial activity of biapenem against recent clinical isolates].
Topics: Bacteria; Bacterial Infections; beta-Alanine; Carbapenems; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Bacterial; Humans; Imipenem; Meropenem; Thienamycins | 2003 |
[Proper use of carbapenem antibiotics based on the feature in the treatment of infectious diseases (discussion)]].
Topics: Bacteria; Bacterial Infections; beta-Alanine; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Administration Schedule; Drug Combinations; Drug Resistance, Bacterial; Humans; Imipenem; Meropenem; Thienamycins; Treatment Failure | 2004 |